Clinical, psychological and quality of life outcomes up to 12-months following thrombosis with thrombocytopenia syndrome after ChAdOx1-S (AZD1222) vaccination in Australia Read more about Clinical, psychological and quality of life outcomes up to 12-months following thrombosis with thrombocytopenia syndrome after ChAdOx1-S (AZD1222) vaccination in Australia2 views
Immunisation against vaccine-preventable diseases in individuals receiving immunosuppressive targeted therapies Read more about Immunisation against vaccine-preventable diseases in individuals receiving immunosuppressive targeted therapies1 view
Improving school vaccinations for adolescents with intellectual and developmental disabilities: a person-centred approach Read more about Improving school vaccinations for adolescents with intellectual and developmental disabilities: a person-centred approach2 views
Electronic, self-reported active vaccine safety surveillance: a three-country comparison of AusVaxSafety (Australia), CANVAS (Canada) and V-safe (United States) Read more about Electronic, self-reported active vaccine safety surveillance: a three-country comparison of AusVaxSafety (Australia), CANVAS (Canada) and V-safe (United States)5 views
Immunogenicity and safety of a 2 + 1 DTPa priming schedule in Australian infants and the impact of maternally derived antibodies on pertussis antibody responses up to 4 years of age Read more about Immunogenicity and safety of a 2 + 1 DTPa priming schedule in Australian infants and the impact of maternally derived antibodies on pertussis antibody responses up to 4 years of age9 views
The role of serological testing for vaccination with a focus on immunocompromised patients: a synthesis of current evidence Read more about The role of serological testing for vaccination with a focus on immunocompromised patients: a synthesis of current evidence11 views
Surveillance of adverse events following immunisation in Australia, COVID-19 vaccines, 2022 Submitted by Jackson.young on Fri, 19/09/2025 The Therapeutic Goods Administration monitors the safety of vaccines in Australia by collecting and reviewing spontaneous reports of adverse events following immunisation. This report describes the data collected through this spontaneous surveillance system in 2022 for all vaccines other than COVID-19 vaccines. Read more about Surveillance of adverse events following immunisation in Australia, COVID-19 vaccines, 2022136 views
Reduction in self-reported adverse events in Australian adults after change to national immunisation schedule from polysaccharide to conjugate pneumococcal vaccine, 2016-2022 Read more about Reduction in self-reported adverse events in Australian adults after change to national immunisation schedule from polysaccharide to conjugate pneumococcal vaccine, 2016-202212 views
Management and outcomes of children hospitalised with COVID-19 including incidental and nosocomial infections in Australia 2020-2023: a national surveillance study Read more about Management and outcomes of children hospitalised with COVID-19 including incidental and nosocomial infections in Australia 2020-2023: a national surveillance study14 views
The Australian Immunisation Register (AIR): insights from working with AIR data Read more about The Australian Immunisation Register (AIR): insights from working with AIR data21 views
